Main D C, Waterman A E, Kilpatrick I C, Jones A
Department of Clinical Veterinary Science, University of Bristol, Langford, UK.
J Vet Pharmacol Ther. 1997 Jun;20(3):220-8. doi: 10.1111/j.1365-2885.1997.tb00099.x.
A modification of the intravenous regional anaesthesia technique was used to assess the peripheral antinociceptive effect of remoxipride, clonidine and fentanyl. Drugs administered intravenously via peripheral catheters were restricted to the distal limb and nociceptive threshold test site by prior inflation of a tourniquet proximal to both the catheter and a threshold-testing device. Lignocaine (1 mg/kg) induced peripheral antinociception during tourniquet inflation. Clonidine (6 micrograms/kg) only induced significant elevations in thresholds after tourniquet deflation. A low dose of remoxipride (2 mg/kg), which had no systemic antinociceptive effect, produced antinociception after its restriction to the periphery. Peripheral administration of saline and tourniquet-induced restriction of blood flow to the distal limb did not alter threshold values. Peripheral administration of fentanyl was used to test a further modification of the injection protocol designed to reduce the incidence of leakage into the systemic circulation. Fentanyl administration (11.2 micrograms/kg) failed to elicit an increase in thresholds when it was restricted to the distal limb test site. The contribution of a peripheral mechanism to the antinociception induced by systemic administration of a higher remoxipride dose (7.5 mg/kg) was investigated using an inflated tourniquet to exclude remoxipride from the periphery. Exclusion of remoxipride from the periphery reduced its antinociceptive effect, i.e. threshold values were lower than if remoxipride was allowed free access to the limb prior to tourniquet inflation. The technique described here was effective in demonstrating that the increase in noninflammatory nociceptive thresholds seen with clonidine and fentanyl is not peripherally mediated whilst that seen with remoxipride has a peripheral component.
采用静脉区域麻醉技术的一种改良方法来评估瑞莫必利、可乐定和芬太尼的外周抗伤害感受作用。通过在靠近外周导管和阈值测试装置的近端预先充气止血带,经外周导管静脉给药的药物被限制在肢体远端和伤害感受阈值测试部位。在止血带充气期间,利多卡因(1mg/kg)可诱导外周抗伤害感受。可乐定(6μg/kg)仅在止血带放气后才使阈值显著升高。低剂量的瑞莫必利(2mg/kg)无全身抗伤害感受作用,将其限制于外周后可产生抗伤害感受。外周给予生理盐水以及止血带诱导的肢体远端血流受限并未改变阈值。外周给予芬太尼用于测试旨在降低漏入体循环发生率的注射方案的进一步改良。当将芬太尼(11.2μg/kg)限制于肢体远端测试部位给药时,未能引起阈值升高。使用充气止血带将瑞莫必利排除在外周,研究外周机制对更高剂量瑞莫必利(7.5mg/kg)全身给药诱导的抗伤害感受的贡献。将瑞莫必利排除在外周可降低其抗伤害感受作用,即阈值低于在止血带充气前允许瑞莫必利自由进入肢体时的阈值。本文所述技术有效地证明了可乐定和芬太尼引起的非炎性伤害感受阈值升高并非由外周介导,而瑞莫必利引起的升高具有外周成分。